Cargando…
P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
High-grade serous ovarian cancer (HGSOC) is a heterogeneous disease for which there currentlyis no cure. Because p53 is mutated in >90% of all ovarian cancer, we studied specific gain-of-function (GOF) p53 mutants and steroid hormones for tumor morphology and metastasis in vivo. For this, we anal...
Autores principales: | Candelaria, Nicholes, Padmanabhan, Achuth, Lanz, Rainer, Wong, Kwong, Richards, JoAnne S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090435/ http://dx.doi.org/10.1210/jendso/bvab048.1567 |
Ejemplares similares
-
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells
por: Padmanabhan, Achuth, et al.
Publicado: (2018) -
Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018) -
MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020) -
SAT361 A Rare Case of Ovarian Steroid Cell Tumor in a Patient With Known Polycystic Ovarian Syndrome
por: Aluko, Oluwatomisin A, et al.
Publicado: (2023) -
Heterozygous Eif4nif1 Stop Gain Mice Replicate the Primary Ovarian Insufficiency Phenotype
por: Moriwaki, Mika, et al.
Publicado: (2021)